Alzamend Neuro, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Alzamend Neuro, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q1 2020 to Q2 2024.
  • Alzamend Neuro, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending July 31, 2024 was -$55M, a 15.5% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$55M -$7.39M -15.5% Jul 31, 2024 10-Q 2024-09-11
Q1 2024 -$54M -$9.95M -22.6% Apr 30, 2024 10-Q 2024-09-11
Q4 2023 -$53.2M -$12.4M -30.4% Jan 31, 2024 10-Q 2024-03-25
Q3 2023 -$50.5M -$15.2M -42.9% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 -$47.6M -$15.4M -47.7% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 -$44.1M -$14.9M -51% Apr 30, 2023 10-K 2024-07-30
Q4 2022 -$40.8M -$15.4M -61% Jan 31, 2023 10-Q 2023-03-15
Q3 2022 -$35.3M -$12.6M -55.3% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 -$32.2M -$13.1M -68.3% Jul 31, 2022 10-Q 2022-09-13
Q1 2022 -$29.2M -$12.4M -73.4% Apr 30, 2022 10-K 2023-07-27
Q4 2021 -$25.3M Jan 31, 2022 10-Q 2022-03-15
Q3 2021 -$22.8M Oct 31, 2021 10-Q 2021-12-13
Q2 2021 -$19.2M Jul 1, 2021 10-Q 2021-09-13
Q1 2021 -$16.8M -$5.05M -42.8% Apr 30, 2021 10-K 2022-07-19
Q1 2020 -$11.8M Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.